


Ask a doctor about a prescription for ALGIFAST 400 mg POWDER FOR ORAL SUSPENSION
Package Leaflet: Information for the User
Algifast 400 mg Powder for Oral Suspension
Ibuprofen (Lysine)
Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.
Follow the administration instructions for the medication contained in this package leaflet or as indicated by your doctor or pharmacist.
Contents of the Package Leaflet
Ibuprofen, the active ingredient in this medication, acts by reducing pain and fever.
This medication is used in adults for the symptomatic relief of occasional mild or moderate pain, such as headaches, dental pain, menstrual pain, muscle pain (cramps) or back pain (lumbago), as well as in febrile states.
You should consult a doctor if your symptoms worsen or do not improve, if the fever persists for more than 3 days or the pain for more than 5 days.
Do not take Algifast if:

Warnings and Precautions
Consult your doctor or pharmacist before starting to take this medication.
Serious skin reactions have been reported in association with ibuprofen treatment.
Stop taking this medication and seek medical attention immediately if you experience any skin rash, lesions on the mucous membranes, blisters, or other signs of allergy, as these may be the first signs of a serious skin reaction. See section 4.
Infections
Ibuprofen may mask the signs of an infection, such as fever and pain. Consequently, this medication may delay appropriate treatment of the infection, which may increase the risk of complications. This has been observed in bacterial pneumonia and bacterial skin infections related to chickenpox. If you take this medication while having an infection and the symptoms of the infection persist or worsen, consult a doctor without delay.
Interference with Laboratory Tests:
If you are going to have any diagnostic tests (including blood tests, urine tests, etc.), inform your doctor that you are taking this medication, as it may alter the results.
Other Medications and Algifast
Inform your doctor or pharmacist if you are using, have recently used, or may need to use any other medication, including those purchased without a prescription.
This medication may affect or be affected by other medications. For example:

If your doctor has prescribed an antiplatelet medication(to prevent blood clot formation) that contains acetylsalicylic acid, and you also take this medication, you should separate the intake of both medications (see Warnings and Precautions section).
Other medications may also affect or be affected by treatment with this medication. Therefore, you should always consult your doctor or pharmacist before using Algifast with other medications.
Taking Algifast with Food, Drinks, and Alcohol
Take this medication with meals or with milk.
Consuming alcohol during treatment may increase the risk of gastrointestinal adverse reactions.
Pregnancy, Breastfeeding, and Fertility
If you are pregnant or breastfeeding, or think you may be pregnant or plan to become pregnant, consult your doctor or pharmacist before using this medication.
The use of ibuprofen should be avoided during the first and second trimester of pregnancy. If it is considered essential, your doctor will prescribe the lowest effective dose for the shortest possible time. It should not be used in the last trimester of pregnancy.
Ibuprofen belongs to a group of medications that may decrease fertility (ability to become pregnant) in women. This effect is reversible when the medication is stopped.
Driving and Using Machines
Although it is not expected to have effects in this regard, it should be used with caution if you experience drowsiness or dizziness.
Algifast contains cyclodextrin (betadex) (E-459), tartrazine (E-102), sucrose, and sodium.
Follow the administration instructions for the medication contained in this package leaflet or as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist.
Use the lowest effective dose for the shortest necessary time to relieve symptoms. If you have an infection, consult your doctor without delay if the symptoms (such as fever and pain) persist or worsen (see section 2).
Adults and adolescents from 12 years old (and over 40 kg in weight)
It is recommended to take 1 sachet (400 mg of ibuprofen) every 6-8 hours, depending on the intensity of the symptoms. Do not take more than 1200 mg of ibuprofen (3 sachets) in 24 hours.
Elderly patients
The dose should be established by the doctor, as it may be necessary to reduce the usual dose. Consult your doctor.
Patients with kidney, liver, or heart disease:
They should consult their doctor before taking this medication.
The administration of this medication is subject to the appearance of pain or fever. As these disappear, the medication should be discontinued.
If the symptoms worsen, if the fever persists for more than 3 days or the pain for more than 5 days, you should consult your doctor.
Method of administration:
This medication is administered orally.
Pour the contents of a sachet into a half glass of water, shake, and take immediately.
Take the medication with meals or with milk, especially if you experience digestive discomfort.
If you take more Algifast than you should
If you have taken more medication than you should, or if a child has accidentally ingested the medication, consult your doctor or pharmacist immediately or call the Toxicology Information Service (telephone 91 562 04 20) indicating the medication and the amount ingested, or go to the nearest hospital to find out about the risk and ask for advice on the measures to be taken.
Symptoms of overdose may include nausea, stomach pain, vomiting (which may contain blood), headache, ringing in the ears, confusion, and involuntary eye movement. At high doses, symptoms such as drowsiness, chest pain, palpitations, loss of consciousness, convulsions (mainly in children), weakness, and dizziness, blood in the urine, chills, and breathing problems have been reported.
Like all medications, this medication can cause side effects, although not everyone will experience them.
Frequent (may affect up to 1 in 10 people): fatigue, headache, stomach and intestine disorders (heartburn, diarrhea, nausea, vomiting), skin disorders (rash, itching), and ringing in the ears.
Uncommon (may affect up to 1 in 100 people): allergic reactions, asthma, rhinitis (inflammation of the nasal mucosa), and urticaria (hives on the skin and intense itching), gastrointestinal bleeding and ulcers, sleep disturbances and mild restlessness, blurred vision, decreased visual acuity, or changes in color perception, and hearing disorders.
Rare (may affect up to 1 in 1,000 people): edema (swelling due to fluid retention), blood disorders (leukopenia), stomach and intestine perforation, liver disorders (including jaundice, i.e., yellowing of the skin and eyes), kidney disorders consisting of acute interstitial nephritis with hematuria (blood in urine), proteinuria (protein elimination in urine), and occasionally nephrotic syndrome (a set of symptoms that appear as a result of kidney damage); depression, vision disorders (vision loss), neck stiffness, and bronchospasm (sudden feeling of shortness of breath), dyspnea (difficulty breathing), and angioedema (inflammation of the deep skin layers, which can cause swelling of the face, lips, tongue, or throat, potentially leading to difficulty swallowing or breathing).
Very rare (may affect up to 1 in 10,000 people): aseptic meningitis (inflammation of the meninges not caused by bacteria), blood and coagulation disorders, hypertension, and heart failure, severe skin, eye, and mucous membrane disorders such as Stevens-Johnson syndrome (a severe skin condition) and toxic epidermal necrolysis (skin and mucous membrane lesions that cause skin detachment) and erythema multiforme (skin inflammation).
Frequency not known: a serious skin reaction known as DRESS syndrome may occur. The symptoms of DRESS syndrome include skin rash, lymph node inflammation, and elevated eosinophils (a type of white blood cell). Generalized red scaly rash, with bumps under the skin and blisters mainly in skin folds, trunk, and upper limbs, accompanied by fever at the start of treatment (acute generalized exanthematous pustulosis). Stop taking Algifast if you experience these symptoms and seek medical attention immediately.
See also section 2. The skin becomes sensitive to light.
Reporting Side Effects
If you experience any side effects, consult your doctor, pharmacist, or nurse, even if they are not listed in this package leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medications: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
No special storage conditions are required.
Once the sachet is opened, the suspension should be prepared immediately according to the instructions for use.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date shown on the sachet and the box after the EXP date. The expiration date is the last day of the month indicated.
Do not use this medication if you notice signs of deterioration.
Medications should not be disposed of through wastewater or household waste. Deposit the packaging and medications you no longer need at the SIGRE collection point in your pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.
Composition of Algifast
Appearance of Algifastand Packaging Content
Fine powder, white in color and lemon-scented, presented in sachets.
Each package contains 4 or 12 sachets.
Marketing Authorization Holder and ManufacturerLABORATORIO DE APLICACIONES FARMACODINÁMICAS, S.A. (FARDI)
Grassot, 16 - 08025- Barcelona (Spain)
Phone: 932073751
Fax: 934570737
e-mail: [email protected]
Date of the Last Revision of this Leaflet:January 2021
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for ALGIFAST 400 mg POWDER FOR ORAL SUSPENSION – subject to medical assessment and local rules.